Lifecore Biomedical, Inc. LFCR Proceeds From Long Term Lines Of Credit
Proceeds From Long Term Lines Of Credit at other companies
Other financials
Where this comes from
Reported directly by Lifecore Biomedical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromLongTermLinesOfCredit.
The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lifecore Biomedical, Inc.'s proceeds from long term lines of credit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lifecore Biomedical, Inc.'s proceeds from long term lines of credit?
- Lifecore Biomedical, Inc. (LFCR) reported proceeds from long term lines of credit of $36.4M in Q1 2026.
- What does proceeds from long term lines of credit mean?
- Represents the total cash inflows received from drawing down on long-term revolving credit facilities or debt lines. This metric indicates the company's reliance on external debt financing to support working capital needs, capital expenditures, or general corporate purposes. It is a key indicator of liquidity management and the company's ability to access credit markets.